ImmunoPrecise Antibodies Ltd (TSE:IPA – Get Rating) Director Gregory Stuart Smith purchased 3,500 shares of ImmunoPrecise Antibodies stock in a transaction dated Friday, September 23rd. The stock was bought at an average price of C$5.41 per share, with a total value of C$18,935.00. Following the acquisition, the director now directly owns 42,500 shares of the company's stock, valued at C$229,925.
Gregory Stuart Smith also recently made the following trade(s):
Get ImmunoPrecise Antibodies alerts:- On Monday, August 15th, Gregory Stuart Smith purchased 5,000 shares of ImmunoPrecise Antibodies stock. The stock was bought at an average price of C$6.93 per share, with a total value of C$34,670.00.
ImmunoPrecise Antibodies Price Performance
ImmunoPrecise Antibodies Company Profile
(Get Rating)
IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The Company aims to transform the conventional, multi-vendor, product development model by bringing innovative and high-throughput, data-driven technologies to its partners, incorporating the advantages of diverse antibody repertoires with the Company's therapeutic antibody discovery suite of technologies, to exploit antibodies of broad epitope coverage, multiple antibody formats, valency and size, and to discover antibodies against multiple/rare epitopes.Featured Articles
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.